Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Public ClinicalTrials.gov record NCT05217927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.
Study identification
- NCT ID
- NCT05217927
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,415 participants
Conditions and interventions
Conditions
Interventions
- Rimegepant 75mg daily dosing Drug
- Rimegepant 75mg every other day dosing Drug
- Placebo comparator dosing Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 4, 2022 (Actual)
- Primary completion
- Oct 22, 2024 (Actual)
- Completion
- Dec 11, 2024 (Actual)
- Last update posted
- Dec 16, 2025
2022 – 2024
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AMR Clinical | Tempe | Arizona | 85281 | — |
| Axiom Research, Llc | Colton | California | 92324 | — |
| Clinical Research Institute | Los Angeles | California | 90048 | — |
| Wr-Pri, Llc | Newport Beach | California | 92660 | — |
| California Neuroscience Research Medical Group, inc. | Sherman Oaks | California | 91403 | — |
| Neurology Offices of South Florida, PLLC | Boca Raton | Florida | 33428 | — |
| AppleMed Research Group, LLC | Miami | Florida | 33126 | — |
| Clinical Investigation Specialists, Inc. | Gurnee | Illinois | 60031 | — |
| MediSphere Medical Research Center, LLC | Evansville | Indiana | 47714 | — |
| Collective Medical Research | Overland Park | Kansas | 66210 | — |
| Clinvest Research, LLC | Springfield | Missouri | 65807 | — |
| Alliance for Multispecialty Research, LLC | Las Vegas | Nevada | 89119 | — |
| Dent Neurosciences Research Center, Inc. | Amherst | New York | 14226 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Upstate Clinical Research Associates, LLC | Williamsville | New York | 14221 | — |
| Wellnow Urgent Care and Research | Columbus | Ohio | 43228 | — |
| Hometown Urgent Care and Research | Huber Heights | Ohio | 45424 | — |
| Velocity Clinical Research, Medford | Medford | Oregon | 97504 | — |
| Preferred Primary Care Physicians, Inc. | Pittsburgh | Pennsylvania | 15236 | — |
| Velocity Clinical Research - Providence | East Greenwich | Rhode Island | 02818 | — |
| Velocity Clinical Research - Columbia | Columbia | South Carolina | 29204 | — |
| Velocity Clinical Research, Gaffney | Gaffney | South Carolina | 29340 | — |
| Tribe Clinical Research LLC | Greenville | South Carolina | 29607 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | — |
| FutureSearch Trials of Dallas, LP | Dallas | Texas | 75231 | — |
| Texas Center for Drug Development, Inc. | Houston | Texas | 77081 | — |
| APD Clinical Research | Magnolia | Texas | 77355 | — |
| Wasatch Clinical Research , LLC(Administrative Location) | Salt Lake City | Utah | 84107 | — |
| Seattle Clinical Research Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05217927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05217927 live on ClinicalTrials.gov.